$RIGL
Market Cap:
$466.6 Million
Financial Snapshot
Revenue
$157.5M
TTM
Gross Margin
90.11%
TTM
Net Earnings
$3.881M
TTM
Current Ratio
196.03%
Q3 2024
Book Value
-$14.64M
Q3 2024
P/E
120.2
Nov 29, 2024 EST
Free Cash Flow
$10.36M
TTM
Revenues
Revenues
Loading...
Loading...
Revenue YoY Change
Loading...
Loading...
Revenues
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $116.9M | $120.2M | $149.2M | $108.6M | $59.29M | $44.51M | $4.500M | $20.40M | $28.90M | $8.300M | $7.200M | $2.300M | $4.800M | $125.0M | $800.0K | $0.00 | $12.60M | $33.50M | $16.50M | $4.700M | $11.10M | $15.80M | $15.30M | $13.20M | $9.000M | $0.00 | $0.00 |
| YoY Change | -2.79% | -19.43% | 37.39% | 83.21% | 33.2% | 889.09% | -77.94% | -29.41% | 248.19% | 15.28% | 213.04% | -52.08% | -96.16% | 15525.0% | -100.0% | -62.39% | 103.03% | 251.06% | -57.66% | -29.75% | 3.27% | 15.91% | 46.67% |
Expenses
Cost Of Revenues
Loading...
Loading...
Gross Profit
Loading...
Loading...
Gross Profit Margin
Loading...
Loading...
Gross Profit
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $116.9M | $120.2M | $149.2M | $108.6M | $59.29M | $44.51M | $4.500M | $20.40M | $28.90M | $8.300M | $7.200M | $2.300M | $4.800M | $125.0M | $800.0K | $0.00 | $12.60M | $33.50M | $16.50M | $4.700M | $11.10M | $15.80M | $15.30M | $13.20M | $9.000M | $0.00 | $0.00 |
| Cost Of Revenue | $7.110M | $1.749M | $1.083M | $895.0K | $906.0K | $287.0K | |||||||||||||||||||||
| Gross Profit | $109.8M | $118.5M | $148.2M | $107.7M | $58.38M | $44.22M | |||||||||||||||||||||
| Gross Profit Margin | 93.92% | 98.55% | 99.27% | 99.18% | 98.47% | 99.36% |
Selling, General & Admin Expense
Loading...
Loading...
Research & Development
Loading...
Loading...
Depreciation, Depletion & Amortization
Loading...
Loading...
SGA Expense to Gross Profit Ratio
Loading...
Loading...
R&D To Gross Profit Ratio
Loading...
Loading...
DDA To Gross Profit Ratio
Loading...
Loading...
Operating Expenses Total
Loading...
Loading...
Operating Profits/Loss
Loading...
Loading...
Operational Expenses
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General & Admin | $105.7M | $112.5M | $91.89M | $76.60M | $74.59M | $70.00M | $37.80M | $21.40M | $17.80M | $22.50M | $19.60M | $22.80M | $21.80M | $25.30M | $20.90M | $27.00M | $21.80M | $19.60M | $12.40M | $13.10M | $11.20M | $10.00M | $9.500M | $15.90M | $6.300M | $2.200M | $1.000M |
| YoY Change | -5.97% | 22.37% | 19.97% | 2.69% | 6.55% | 85.19% | 76.64% | 20.22% | -20.89% | 14.8% | -14.04% | 4.59% | -13.83% | 21.05% | -22.59% | 23.85% | 11.22% | 58.06% | -5.34% | 16.96% | 12.0% | 5.26% | -40.25% | 152.38% | 186.36% | 120.0% | 900.0% |
| % of Gross Profit | 96.33% | 94.9% | 62.02% | 71.1% | 127.76% | 158.3% | |||||||||||||||||||||
| Research & Development | $24.52M | $60.27M | $65.24M | $60.10M | $52.89M | $46.90M | $46.30M | $63.40M | $62.80M | $67.70M | $75.33M | $78.78M | $69.35M | $64.39M | $90.74M | $109.7M | $70.40M | $57.00M | $52.00M | $48.50M | $40.70M | $42.80M | $30.70M | $22.90M | $14.80M | $8.300M | $4.600M |
| YoY Change | -59.31% | -7.61% | 8.55% | 13.64% | 12.75% | 1.3% | -26.97% | 0.96% | -7.24% | -10.13% | -4.38% | 13.59% | 7.7% | -29.04% | -17.28% | 55.82% | 23.51% | 9.62% | 7.22% | 19.16% | -4.91% | 39.41% | 34.06% | 54.73% | 78.31% | 80.43% | |
| % of Gross Profit | 22.34% | 50.87% | 44.03% | 55.79% | 90.58% | 106.06% | |||||||||||||||||||||
| Depreciation & Amortization | $1.238M | $998.0K | $1.200M | $700.0K | $700.0K | $594.0K | $470.0K | $940.0K | $1.440M | $2.360M | $2.592M | $2.433M | $1.955M | $1.317M | $1.403M | $1.430M | $1.340M | $1.420M | $1.150M | $2.250M | $2.660M | $4.870M | $4.130M | $2.680M | $1.910M | $1.100M | $410.0K |
| YoY Change | 24.05% | -16.83% | 71.43% | 0.0% | 17.85% | 26.38% | -50.0% | -34.72% | -38.98% | -8.95% | 6.54% | 24.45% | 48.44% | -6.13% | -1.89% | 6.72% | -5.63% | 23.48% | -48.89% | -15.41% | -45.38% | 17.92% | 54.1% | 40.31% | 73.64% | 168.29% | |
| % of Gross Profit | 1.13% | 0.84% | 0.81% | 0.65% | 1.2% | 1.34% | |||||||||||||||||||||
| Operating Expenses | $130.3M | $172.7M | $157.1M | $136.7M | $127.5M | $116.9M | $84.10M | $84.80M | $80.60M | $90.20M | $75.33M | $78.78M | $69.35M | $64.39M | $90.74M | $136.7M | $92.10M | $76.50M | $64.40M | $61.60M | $51.90M | $52.80M | $40.30M | $38.70M | $21.10M | $10.50M | $5.600M |
| YoY Change | -24.58% | 9.93% | 14.94% | 7.24% | 9.04% | 39.01% | -0.83% | 5.21% | -10.64% | 19.74% | -4.38% | 13.59% | 7.7% | -29.04% | -33.62% | 48.43% | 20.39% | 18.79% | 4.55% | 18.69% | -1.7% | 31.02% | 4.13% | 83.41% | 100.95% | 87.5% | 5500.0% |
| Operating Profit | -$20.49M | -$55.55M | -$12.50M | -$28.97M | -$69.09M | -$72.68M | -$89.47M | -$99.38M | -$86.37M | $35.32M | -$112.0M | ||||||||||||||||
| YoY Change | -63.11% | 344.54% | -56.87% | -58.07% | -4.94% | -9.97% | 15.06% | -344.55% | -131.52% |
Interest Expenses
Loading...
Loading...
Interest Expenses To Operating Income %
Loading...
Loading...
Other Expense/Income
Loading...
Loading...
Interest & Other Expense/Income
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Expense | $6.872M | $3.707M | $4.860M | $1.353M | $335.0K | $2.200M | $900.0K | $400.0K | $200.0K | $200.0K | $400.0K | $500.0K | $25.00K | $91.00K | $203.0K | $4.300M | $5.300M | $5.400M | $2.700M | $600.0K | -$200.0K | $0.00 | $1.200M | $100.0K | -$300.0K | -$100.0K | $100.0K |
| YoY Change | 85.38% | -23.72% | 259.2% | 303.88% | -84.77% | 144.44% | 125.0% | 100.0% | 0.0% | -50.0% | -20.0% | 1900.0% | -72.53% | -55.17% | -95.28% | -18.87% | -1.85% | 100.0% | 350.0% | -400.0% | -100.0% | 1100.0% | -133.33% | 200.0% | -200.0% | ||
| % of Operating Profit | 0.26% | ||||||||||||||||||||||||||
| Other Income/Expense, Net | $0.00 | $0.00 | $2.400M | $0.00 | $0.00 | ||||||||||||||||||||||
| YoY Change | -100.0% |
Income/Loss
Pretax Income
Loading...
Loading...
Income Tax
Loading...
Loading...
Net Profits/Loss
Loading...
Loading...
Pretax Income YoY Change
Loading...
Loading...
Income Tax Rate
Loading...
Loading...
Net Profits/Loss YoY Change
Loading...
Loading...
Basic EPS
Loading...
Loading...
Net Income To Revenue Ratio
Loading...
Loading...
Pretax & Net Income
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pretax Income | -$25.09M | -$58.57M | -$17.31M | -$29.74M | -$66.89M | -$70.50M | -$78.00M | -$69.20M | -$51.50M | -$90.90M | -$89.00M | -$98.80M | -$85.97M | $37.89M | -$111.6M | -$132.4M | -$74.30M | -$37.60M | -$45.30M | -$56.30M | -$41.20M | -$37.00M | -$23.80M | -$25.40M | -$12.40M | -$10.60M | -$5.500M |
| YoY Change | -57.16% | 238.4% | -41.81% | -55.54% | -5.11% | -9.62% | 12.72% | 34.37% | -43.34% | 2.13% | -9.92% | 14.92% | -326.9% | -133.94% | -15.68% | 78.2% | 97.61% | -17.0% | -19.54% | 36.65% | 11.35% | 55.46% | -6.3% | 104.84% | 16.98% | 92.73% | 5400.0% |
| Income Tax | $0.00 | $600.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$100.0K | -$100.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| % Of Pretax Income | 0.0% | ||||||||||||||||||||||||||
| Net Earnings | -$25.09M | -$58.57M | -$17.91M | -$29.74M | -$66.89M | -$70.48M | -$78.00M | -$69.20M | -$51.50M | -$90.90M | -$89.00M | -$98.80M | -$86.00M | $37.90M | -$111.5M | -$132.3M | -$74.30M | -$37.60M | -$45.30M | -$56.30M | -$41.20M | -$37.00M | -$23.80M | -$25.40M | -$12.40M | -$10.60M | -$5.500M |
| YoY Change | -57.16% | 226.97% | -39.77% | -55.54% | -5.09% | -9.64% | 12.72% | 34.37% | -43.34% | 2.13% | -9.92% | 14.88% | -326.91% | -133.99% | -15.72% | 78.06% | 97.61% | -17.0% | -19.54% | 36.65% | 11.35% | 55.46% | -6.3% | 104.84% | 16.98% | 92.73% | 5400.0% |
| Net Earnings / Revenue | -21.47% | -48.71% | -12.0% | -27.38% | -112.83% | -158.35% | -1733.33% | -339.22% | -178.2% | -1095.18% | -1236.11% | -4295.65% | -1791.67% | 30.32% | -13937.5% | -589.68% | -112.24% | -274.55% | -1197.87% | -371.17% | -234.18% | -155.56% | -192.42% | -137.78% | |||
| Basic Earnings Per Share | -$0.14 | -$0.34 | -$0.11 | -$0.18 | -$0.40 | -$1.32 | -$1.36 | $0.73 | -$2.73 | ||||||||||||||||||
| Diluted Earnings Per Share | -$0.14 | -$0.34 | -$0.11 | -$0.18 | -$0.40 | -$439.3K | -$617.6K | -$733.1K | -$582.6K | -$1.036M | -$1.019M | -$1.32 | -$1.36 | $0.72 | -$2.73 | -$3.675M | -$2.571M | -$1.510M | -$2.068M | -$3.110M | -$3.614M | -$7.400M | -$5.805M | -$31.75M | -$41.33M | -$35.33M | -$18.33M |
Assets & Liabilities
Cash & Short-Term Investments
Loading...
Loading...
Cash & Equivalents
Loading...
Loading...
Cash To Operating Expenses Ratio
Loading...
Loading...
Inventory
Loading...
Loading...
Receivables
Loading...
Loading...
Total Short-Term Assets
Loading...
Loading...
Property, Plant And Equipment
Loading...
Loading...
Long-Term Investments
Loading...
Loading...
Total Long-Term Assets
Loading...
Loading...
Total Assets
Loading...
Loading...
Net Income To Total Assets Percentage
Loading...
Loading...
Accounts Payable
Loading...
Loading...
Short-Term Debt
Loading...
Loading...
Long Term Debt Due
Loading...
Loading...
Total Short-Term Liabilities
Loading...
Loading...
Long-Term Debt
Loading...
Loading...
Other Long-Term Liabilities
Loading...
Loading...
Total Long-Term Liabilities
Loading...
Loading...
Total Liabilities
Loading...
Loading...
Short-Term To Long-Term Debt Ratio
Loading...
Loading...
Short-Term Assets To Debt Ratio
Loading...
Loading...
Long-Term Debt To Net Income Ratio
Loading...
Loading...
Assets & Liabilities
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Short-Term Investments | $56.93M | $58.21M | $125.0M | $57.30M | $98.10M | $128.5M | $115.8M | $74.80M | $126.3M | $143.2M | $212.0M | $298.2M | $247.6M | $177.3M | $133.3M | $134.5M | $108.3M | $104.5M | $138.2M | $71.40M | $46.50M | $27.30M | $33.40M | $53.00M | $5.800M | $9.500M | |
| YoY Change | -2.19% | -53.42% | 118.09% | -41.59% | -23.66% | 10.97% | 54.81% | -40.78% | -11.8% | -32.45% | -28.91% | 20.44% | 39.65% | 33.01% | -0.89% | 24.19% | 3.64% | -24.38% | 93.56% | 53.55% | 70.33% | -18.26% | -36.98% | 813.79% | -38.95% | ||
| Cash & Equivalents | $32.79M | $24.46M | $18.89M | $30.40M | $22.50M | $76.30M | $38.30M | $17.60M | $43.50M | $15.20M | $20.90M | $33.50M | $18.60M | $8.900M | $14.70M | $46.00M | $44.50M | $47.70M | $76.80M | $10.50M | $9.600M | $26.50M | $11.50M | $49.00M | $5.800M | $9.500M | |
| Short-Term Investments | $24.15M | $33.75M | $106.1M | $27.00M | $75.60M | $52.20M | $77.50M | $57.10M | $82.80M | $128.0M | $191.1M | $264.8M | $229.0M | $168.4M | $118.6M | $88.50M | $63.80M | $56.70M | $61.40M | $60.90M | $36.90M | $800.0K | $21.90M | $4.000M | $0.00 | ||
| Other Short-Term Assets | $6.261M | $8.259M | $7.412M | $14.00M | $9.500M | $3.500M | $1.700M | $1.400M | $2.500M | $1.600M | $2.400M | $4.200M | $2.600M | $2.600M | $2.700M | $3.600M | $2.400M | $2.200M | $2.600M | $2.100M | $2.200M | $1.900M | $1.600M | $1.000M | $300.0K | $100.0K | |
| YoY Change | -24.19% | 11.43% | -47.06% | 47.37% | 171.43% | 105.88% | 21.43% | -44.0% | 56.25% | -33.33% | -42.86% | 61.54% | 0.0% | -3.7% | -25.0% | 50.0% | 9.09% | -15.38% | 23.81% | -4.55% | 15.79% | 18.75% | 60.0% | 233.33% | 200.0% | ||
| Inventory | $5.522M | $9.118M | $6.616M | $1.600M | $1.400M | $900.0K | |||||||||||||||||||||
| Prepaid Expenses | |||||||||||||||||||||||||||
| Receivables | $30.55M | $40.32M | $15.47M | $16.00M | $10.10M | $4.100M | $0.00 | $200.0K | $5.800M | $5.800M | $0.00 | $1.100M | $1.100M | $0.00 | $500.0K | $1.500M | $1.200M | $700.0K | $2.300M | $0.00 | |||||||
| Other Receivables | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $400.0K | $300.0K | $700.0K | $700.0K | $800.0K | $6.200M | $300.0K | $0.00 | $0.00 | $0.00 | |||||||
| Total Short-Term Assets | $99.27M | $115.9M | $154.5M | $89.00M | $119.0M | $137.0M | $117.4M | $76.20M | $129.0M | $150.5M | $220.1M | $302.5M | $250.2M | $179.9M | $136.0M | $138.1M | $111.1M | $108.0M | $142.6M | $74.20M | $50.00M | $36.90M | $36.50M | $54.70M | $8.500M | $9.600M | |
| YoY Change | -14.35% | -24.97% | 73.56% | -25.21% | -13.14% | 16.7% | 54.07% | -40.93% | -14.29% | -31.62% | -27.24% | 20.9% | 39.08% | 32.28% | -1.52% | 24.3% | 2.87% | -24.26% | 92.18% | 48.4% | 35.5% | 1.1% | -33.27% | 543.53% | -11.46% | ||
| Property, Plant & Equipment | $1.026M | $2.787M | $11.89M | $20.60M | $27.90M | $1.400M | $900.0K | $1.200M | $1.600M | $2.500M | $4.500M | $5.800M | $4.900M | $4.500M | $2.300M | $3.600M | $2.600M | $3.000M | $3.500M | $2.800M | $3.500M | $5.200M | $8.400M | $9.300M | $8.400M | $3.200M | |
| YoY Change | -63.19% | -76.55% | -42.3% | -26.16% | 1892.86% | 55.56% | -25.0% | -25.0% | -36.0% | -44.44% | -22.41% | 18.37% | 8.89% | 95.65% | -36.11% | 38.46% | -13.33% | -14.29% | 25.0% | -20.0% | -32.69% | -38.1% | -9.68% | 10.71% | 162.5% | ||
| Goodwill | |||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||
| Intangibles | |||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||
| Long-Term Investments | |||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||
| Other Assets | $3.055M | $640.0K | $974.0K | $800.0K | $700.0K | $700.0K | $800.0K | $800.0K | $1.100M | $1.100M | $1.500M | $1.800M | $2.000M | $2.200M | $2.500M | $2.200M | $2.100M | $2.300M | $1.600M | $1.800M | $2.000M | $2.300M | $1.500M | $200.0K | $200.0K | $100.0K | |
| YoY Change | 377.34% | -34.29% | 21.75% | 14.29% | 0.0% | -12.5% | 0.0% | -27.27% | 0.0% | -26.67% | -16.67% | -10.0% | -9.09% | -12.0% | 13.64% | 4.76% | -8.7% | 43.75% | -11.11% | -10.0% | -13.04% | 53.33% | 650.0% | 0.0% | 100.0% | ||
| Total Long-Term Assets | $17.96M | $18.38M | $12.86M | $21.40M | $28.60M | $2.100M | $1.700M | $1.900M | $2.700M | $3.600M | $6.000M | $7.500M | $6.900M | $6.800M | $4.700M | $5.800M | $4.700M | $5.200M | $5.100M | $4.600M | $5.500M | $7.400M | $9.900M | $9.600M | $8.700M | $3.400M | |
| YoY Change | -2.27% | 42.88% | -39.9% | -25.17% | 1261.9% | 23.53% | -10.53% | -29.63% | -25.0% | -40.0% | -20.0% | 8.7% | 1.47% | 44.68% | -18.97% | 23.4% | -9.62% | 1.96% | 10.87% | -16.36% | -25.68% | -25.25% | 3.13% | 10.34% | 155.88% | ||
| Total Assets | $117.2M | $134.3M | $167.3M | $110.4M | $147.6M | $139.1M | $119.1M | $78.10M | $131.7M | $154.1M | $226.1M | $310.0M | $257.1M | $186.7M | $140.7M | $143.9M | $115.8M | $113.2M | $147.7M | $78.80M | $55.50M | $44.30M | $46.40M | $64.30M | $17.20M | $13.00M | |
| YoY Change | |||||||||||||||||||||||||||
| Accounts Payable | $7.142M | $22.51M | $3.795M | $3.700M | $4.200M | $6.400M | $2.600M | $5.600M | $2.800M | $1.600M | $3.900M | $1.700M | $1.600M | $1.400M | $3.200M | $6.000M | $4.300M | $2.000M | $2.500M | $1.900M | $1.400M | $3.500M | $2.000M | $1.300M | $900.0K | $500.0K | |
| YoY Change | -68.27% | 493.1% | 2.57% | -11.9% | -34.38% | 146.15% | -53.57% | 100.0% | 75.0% | -58.97% | 129.41% | 6.25% | 14.29% | -56.25% | -46.67% | 39.53% | 115.0% | -20.0% | 31.58% | 35.71% | -60.0% | 75.0% | 53.85% | 44.44% | 80.0% | ||
| Accrued Expenses | $18.22M | $24.19M | $43.66M | $34.10M | $28.80M | $20.30M | $15.40M | $11.00M | $12.30M | $7.400M | $5.200M | $9.800M | $9.800M | $9.200M | $13.60M | $13.70M | $10.20M | $4.900M | $4.500M | $3.200M | $2.200M | $3.500M | $1.800M | $1.400M | $1.700M | $1.000M | |
| YoY Change | -24.71% | -44.59% | 28.03% | 18.4% | 41.87% | 31.82% | 40.0% | -10.57% | 66.22% | 42.31% | -46.94% | 0.0% | 6.52% | -32.35% | -0.73% | 34.31% | 108.16% | 8.89% | 40.63% | 45.45% | -37.14% | 94.44% | 28.57% | -17.65% | 70.0% | ||
| Deferred Revenue | |||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||
| Short-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| YoY Change | |||||||||||||||||||||||||||
| Long-Term Debt Due | $7.229M | $800.0K | $1.100M | $1.300M | $1.000M | $1.300M | $1.100M | $1.300M | $2.300M | $3.400M | $3.200M | $3.000M | $2.200M | $700.0K | |||||||||||||
| YoY Change | -27.27% | -15.38% | 30.0% | -23.08% | 18.18% | -15.38% | -43.48% | -32.35% | 6.25% | 6.67% | 36.36% | 214.29% | |||||||||||||||
| Total Short-Term Liabilities | $53.27M | $65.21M | $63.55M | $40.80M | $58.20M | $27.70M | $18.30M | $22.60M | $33.80M | $14.00M | $10.30M | $12.20M | $11.50M | $11.30M | $17.80M | $24.20M | $16.10M | $11.20M | $23.60M | $11.40M | $8.100M | $14.40M | $10.20M | $8.100M | $9.500M | $5.100M | |
| YoY Change | -18.32% | 2.61% | 55.77% | -29.9% | 110.11% | 51.37% | -19.03% | -33.14% | 141.43% | 35.92% | -15.57% | 6.09% | 1.77% | -36.52% | -26.45% | 50.31% | 43.75% | -52.54% | 107.02% | 40.74% | -43.75% | 41.18% | 25.93% | -14.74% | 86.27% | ||
| Long-Term Debt | $52.37M | $39.45M | $19.91M | $19.80M | $9.800M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $900.0K | $2.100M | $800.0K | $1.100M | $1.100M | $800.0K | $1.200M | $2.300M | $4.200M | $5.800M | $5.500M | $1.700M | |
| YoY Change | 32.76% | 98.09% | 0.58% | 102.04% | -100.0% | -57.14% | 162.5% | -27.27% | 0.0% | 37.5% | -33.33% | -47.83% | -45.24% | -27.59% | 5.45% | 223.53% | |||||||||||
| Other Long-Term Liabilities | $40.23M | $43.24M | $53.49M | $15.70M | $25.70M | $1.500M | $100.0K | $500.0K | $6.600M | $11.90M | $7.500M | $8.700M | $9.400M | $9.200M | $12.20M | $13.50M | $16.70M | $13.70M | $14.30M | $14.30M | $6.300M | $2.200M | $3.100M | $1.400M | $1.400M | $800.0K | |
| YoY Change | -6.95% | -19.16% | 240.68% | -38.91% | 1613.33% | 1400.0% | -80.0% | -92.42% | -44.54% | 58.67% | -13.79% | -7.45% | 2.17% | -24.59% | -9.63% | -19.16% | 21.9% | -4.2% | 0.0% | 126.98% | 186.36% | -29.03% | 121.43% | 0.0% | 75.0% | ||
| Total Long-Term Liabilities | $92.60M | $82.68M | $73.40M | $35.50M | $35.50M | $1.500M | $100.0K | $500.0K | $6.600M | $11.90M | $7.500M | $8.700M | $9.400M | $9.200M | $13.10M | $15.60M | $17.50M | $14.80M | $15.40M | $15.10M | $7.500M | $4.500M | $7.300M | $7.200M | $6.900M | $2.500M | |
| YoY Change | 12.0% | 12.65% | 106.76% | 0.0% | 2266.67% | 1400.0% | -80.0% | -92.42% | -44.54% | 58.67% | -13.79% | -7.45% | 2.17% | -29.77% | -16.03% | -10.86% | 18.24% | -3.9% | 1.99% | 101.33% | 66.67% | -38.36% | 1.39% | 4.35% | 176.0% | ||
| Total Liabilities | $145.9M | $147.9M | $137.0M | $76.40M | $93.80M | $29.20M | $18.50M | $23.10M | $40.40M | $25.90M | $17.80M | $20.90M | $21.00M | $20.60M | $30.90M | $39.70M | $33.60M | $26.00M | $39.10M | $26.50M | $15.60M | $18.90M | $17.50M | $15.30M | $16.40M | $7.500M | |
| YoY Change | -1.37% | 7.99% | 79.26% | -18.55% | 221.23% | 57.84% | -19.91% | -42.82% | 55.98% | 45.51% | -14.83% | -0.48% | 1.94% | -33.33% | -22.17% | 18.15% | 29.23% | -33.5% | 47.55% | 69.87% | -17.46% | 8.0% | 14.38% | -6.71% | 118.67% |
Ownership
Basic Shares Outstanding
Loading...
Loading...
Diluted Shares Outstanding
Loading...
Loading...
Preferred Stock
Loading...
Loading...
Treasury Stock Shares
Loading...
Loading...
Stock Issuance & Repurchase
Loading...
Loading...
Ownership Data
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Basic Shares Outstanding | 174.0M | 172.4M | 170.5M | 168.8M | 167.4M | 87.66M | 87.29M shares | 74.97M shares | 63.33M shares | 52.06M shares | 40.88M shares | ||||||||||||||||
| Diluted Shares Outstanding | 174.0M | 172.4M | 170.5M | 168.8M | 167.4M | 87.29M shares | 74.97M shares | 63.33M shares | 52.57M shares | 40.88M shares | |||||||||||||||||
| Preferred Stock | |||||||||||||||||||||||||||
| Treasury Stock Shares |
Return On Shareholders' Equity
Loading...
Loading...
Book Value
Loading...
Loading...
Free Cash Flow
Loading...
Loading...
Free Cash Flow YoY
Loading...
Loading...
Free Cash Flow Margin
Loading...
Loading...
Dividends
Dividends
Loading...
Loading...
Stock Price
Loading...
Market Cap: $466.62 Million
About RIGEL PHARMACEUTICALS INC
Rigel Pharmaceuticals Inc is a US-based company operating in Biotechnology industry. The company is headquartered in South San Francisco, California and currently employs 147 full-time employees. The company went IPO on 2000-11-29. Rigel Pharmaceuticals, Inc. is a biotechnology company. The firm is engaged in developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. The company is focused on products that address signaling pathways that are critical to disease mechanisms. Its first product is TAVALISSE (fostamatinib disodium hexahydrate) tablets, the approved oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. Its second product is REZLIDHIA (olutasidenib) capsules for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. Its GAVRETO (pralsetinib) product is a once daily, small molecule, oral, kinase inhibitor of wild type rearranged during transfection (RET) and oncogenic RET fusions.
Industry: Pharmaceutical Preparations Peers: 89bio, Inc. Evelo Biosciences, Inc. Kronos Bio, Inc. LianBio MACROGENICS INC Shuttle Pharmaceuticals Holdings, Inc. Viking Therapeutics, Inc. Voyager Therapeutics, Inc.
